You're browsing as a guest. Sign in to unlock all features.
ACHV
Achieve Life Sciences·Biotechnology·United States
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company ...
1 Total1 External0 In-site
ACHVAchieve Life Sciences
2025-12-29🏥 HealthcareLong
Externalby Hunterbrook Media · Other
“Put it in the water!” — How a Toxic Tree May Save Thousands of Smokers
Hunterbrook Capital is long $ACHV. Achieve Life Sciences is seeking FDA approval for cytisinicline, a promising smoking cessation therapy. The drug has shown to be safer and more effective than existing treatments and is already used in Europe. With a large addressable market and potential for both anti-smoking and anti-vaping indications, Achieve is well-positioned for growth, although it will need to raise more capital for commercialization.